Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production.

TitleAnti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production.
Publication TypeJournal Article
Year of Publication1993
AuthorsChavin KD, Qin L, Lin J, Kaplan AJ, Bromberg JS
JournalTransplant Proc
Volume25
Issue1 Pt 1
Pagination823-4
Date Published1993 Feb
ISSN0041-1345
KeywordsAnimals, Antibodies, Monoclonal, Antigens, Differentiation, T-Lymphocyte, Antigens, Surface, CD2 Antigens, CD3 Complex, Cytokines, Drug Synergism, Flow Cytometry, Graft Survival, Heart Transplantation, Immunosuppressive Agents, Lymphocyte Activation, Lymphocytes, Mice, Mice, Inbred C57BL, Mice, Inbred CBA, Receptors, Immunologic, Transplantation, Homologous
Alternate JournalTransplant Proc
PubMed ID8094913
Related Faculty: 
Lihui Qin, M.D., Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700